SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001479290-18-000058
Filing Date
2018-03-23
Accepted
2018-03-23 21:12:25
Documents
1
Period of Report
2018-03-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_152185393085906.html 4  
1 FORM 4 wf-form4_152185393085906.xml 4 3781
  Complete submission text file 0001479290-18-000058.txt   5113
Mailing Address 15279 ALTON PARKWAY SUITE #100 IRVINE CA 92618
Business Address
SILVERNAIL LAUREN P (Reporting) CIK: 0001225755 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36297 | Film No.: 18711478

Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Issuer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations